PFE logo

PFE
Pfizer Inc

105,510
Mkt Cap
$141.29B
Volume
124.14M
52W High
$27.69
52W Low
$20.92
PE Ratio
14.48
PFE Fundamentals
Price
$24.90
Prev Close
$24.61
Open
$24.75
50D MA
$24.74
Beta
0.41
Avg. Volume
61.31M
EPS (Annual)
$1.41
P/B
1.52
Rev/Employee
$785,518.52
Loading...
Loading...
News
all
press releases
Pfizer (NYSE:PFE) Stock Price Up 1.3% - Still a Buy?
Pfizer (NYSE:PFE) Trading 1.3% Higher - Still a Buy...
MarketBeat·7h ago
News Placeholder
More News
News Placeholder
Top Dividend Stocks To Research - November 5th
Direxion Daily TSLA Bull 2X Shares, Pfizer, ProShares UltraPro Short QQQ, Amgen, and AT&T are the five Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks...
MarketBeat·9h ago
News Placeholder
Top Pharmaceutical Stocks To Add to Your Watchlist - November 6th
Eli Lilly and Company, Pfizer, Novo Nordisk A/S, 89BIO, McKesson, AbbVie, and Teva Pharmaceutical Industries are the seven Pharmaceutical stocks to watch today, according to MarketBeat's stock...
MarketBeat·11h ago
News Placeholder
Medical Stocks To Watch Now - November 6th
Eli Lilly and Company, Pfizer, Novo Nordisk A/S, UnitedHealth Group, and Hims & Hers Health are the five Medical stocks to watch today, according to MarketBeat's stock screener tool. "Medical stocks...
MarketBeat·11h ago
News Placeholder
Moderna Q3 Earnings Beat, Stock Up on Revised '25 Spending Plans
MRNA posts narrower-than-expected Q3 loss and lifts liquidity outlook for 2025, as cost cuts and revised spending plans boost investor sentiment
Zacks·13h ago
News Placeholder
AZN Q3 Earnings Top Estimates, Sales Rise As Most Key Drugs Outperform
AstraZeneca posts strong Q3 results. Core earnings and revenues beat estimates as key drugs like Tagrisso, Imfinzi and Farxiga fuel broad-based growth.
Zacks·13h ago
News Placeholder
Novo Nordisk Reportedly Refrains From Backing Down In Metsera Acquisition Battle, Sweetens Bid Further
According to an FT report, Pfizer now has two days to match Novo’s new bid or let its agreed-upon deal with Metsera fall through.
Stocktwits·13h ago
News Placeholder
Leerink Partnrs Issues Negative Outlook for Pfizer Earnings
Pfizer Inc. (NYSE:PFE - Free Report) - Analysts at Leerink Partnrs reduced their Q4 2025 earnings estimates for shares of Pfizer in a research report issued to clients and investors on Tuesday...
MarketBeat·17h ago
News Placeholder
Twin Capital Management Inc. Acquires 26,118 Shares of Pfizer Inc. $PFE
Twin Capital Management Inc. lifted its stake in Pfizer Inc. (NYSE:PFE - Free Report) by 39.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat·17h ago
News Placeholder
Novo Nordisk Snaps 11-Day Losing Streak After Court Rejects Pfizer’s Challenge To $10B Metsera Deal
Delaware Chancery Judge Morgan Zurn ruled that Pfizer’s objections did not justify delaying Novo’s $10 billion acquisition of obesity-drug startup Metsera.
Stocktwits·1d ago

Latest PFE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.